StudyFinder

Multimodality Therapy with Immunotherapy in Stage I-IIIA Pleural Mesothelioma

Status: Recruiting

The purpose of this study is to learn the effects, good or bad, of the study drug, vosoritide, for treating children who have hypochondroplasia. This condition affects the growth of bone and cartilage and in which kids who have it are shorter than other kids of the same age. In this study, your child will get either the study drug or placebo, which is an inactive medicine.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• daignosis of Sarcomatoid or sarcomatoid-dominant (> 50%) biphasic, pleural mesothelioma
• have not received treatment
• not pregnant or breastfeeding
• able to do all selfcare but may be unable to carry out any work activities; up and about more than 50% of waking hours
• see link to clinicaltrials.gov for complete inclusion criteria
Exclusion Criteria:

• people who are not able to have surgical treatment
• history of symptomatic interstitial lung disease
• see link to clinicaltrials.gov for complete exclusion criteria
Interventions:

Procedure: Computed Tomography, Biological: Ipilimumab, Procedure: Magnetic Resonance Imaging, Biological: Nivolumab, Procedure: Positron Emission Tomography, Procedure: Surgical Procedure

Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC), lung cancer, Mesothelioma

Study Contact: Robert Kratzke - kratz003@umn.edu
Principal Investigator: Robert Kratzke
Phase: PHASE2
IRB Number: STUDY00026290
See this study on ClinicalTrials.gov

Back